百度试题 题目临床获益率Clinical benefit rate (CBR)= A.CR+PRB.CR+PR+SDC.R+PR+SD > 6 months相关知识点: 试题来源: 解析 C 反馈 收藏
研究的主要终点为无进展生存期(progression-free survival, PFS),次要终点为总生存期(overall survival, OS)、客观缓解率(objective response rate, ORR)、疾病控制率(disease control rate, DCR)、缓解持续时间(duration of response, DoR)、临床获益率(clinical benefit rate, CBR)、安全性和生活质量。从2021年5月...
2) Clinical benefit response 临床受益反应 1. The curative effect was estimated according to the standard of WHO and the clinical benefit response was evaluated at the same time. 目的:观察吉西他滨 (GEM)、氟尿嘧啶 (5 FU)及顺铂 (DDP)三药联合化疗对晚期胰腺癌的客观疗效及其临床受益反应 (CBR)...
In Part II (ESMO 2021), 10 distinct solid tumour types were enrolled to assess preliminary efficacy (overall survival (OS), progression free survival (PFS), and clinical benefit rate (CBR). Clever-1 IHC in pre-treatment biopsies with Ventana platform using a primary antibody 4G9 (Santa Cruz...
网络临床受益反应 网络释义 1. 临床受益反应 研究其疗效,临床受益反应(Clinical benefit response CBR)以及毒性反应对比,效果满意,现报告如下: 1 资料与方法 1.1 临… www.cmed.org.cn|基于3个网页
Compared to patients treated with SBRT/nivolumab, those in the SBRT nivolumab/ipilimumab group achieved a higher clinical benefit rate (CBR) (37.2% vs. 17.1%) and a higher percentage of patients who achieved a PR (14.0% vs. 2.4%). In conclusion, the regimen exhibited clinically significant ...
As of 15 Jun 2021, a total of 76 evaluable patients had received HMPL-689 at RP2D (300mg QD), with median follow-up of 5.6 months. The overall ORR was 53.9% with CR at 11.8% and clinical benefit rate (CBR) at 76.3%. Especially, HMPL-689 showed promising clinical activity in FL ...
MitoTam showed benefit evaluated as clinical benefit rate (CBR) in 37% patients with the largest effect in renal cell carcinoma (RCC) where four out of six patients reached disease stabilisation (SD), one reached partial...
Clinical Benefit Rate (CBR): CBR, defined as the rate of confirmed complete response, partial response, or stable disease ≥24 weeks across all dose levels (n = 46) was 63% (95% CI: 47.5 - 76.8), with a CBR of 72% in patients with mutant ESR1 (n=29; 95% CI: 52.8 - 87.3) ...
Clinical benifit rate临床受益反应率 3)Clinical benefit response临床受益反应 1.The curative effect was estimated according to the standard of WHO and the clinical benefit response was evaluated at the same time.目的 :观察吉西他滨 (GEM)、氟尿嘧啶 (5 FU)及顺铂 (DDP)三药联合化疗对晚期胰腺癌的客观...